Cholesteryl ester transfer protein, low density lipoprotein particle size and intima media thickness in patients with coronary heart disease

Bosnian Journal of Basic Medical Sciences

Volumn 11, Issue 3, 2011, Pages 169-173

  Tosheska, Katerina ^a   Labudovic, Danica ^a   Jovanova, Silvana ^a   Jaglikovski, Branko ^b   Alabakovska, Sonja ^a  

^a SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

^b AVICENA Laboratory   (Macedonia)

Author keywords

Cholesteryl ester transfer protein; Coronary heart disease; Intima media thickness; Reverse cholesterol transport

Indexed keywords

EID: 80052395888     PISSN: 15128601     EISSN: 18404812     Source Type: Journal    
DOI: 10.17305/bjbms.2011.2569     Document Type: Article

References (41)

1. Cooney MT, Dudina A, De Bacquer D, Wilhelmsen L, Sans S, Menotti A, et al. SCORE investigators. HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk. Atherosclerosis 2009; 206(2):611-616.
2. Krauss RM. Is the size of low-density lipoprotein particles related to the risk of coronary heart disease? JAMA 2002; 287(6)712-713.
3. Barter JP, Rye AK. High density lipoproteins and coronary heart disease. Atherosclerosis 1996; 121(1):1-12.
4. Krauss MR, Burke JD. Identifi cation of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 1982; 23(1):97-104.
5. Krauss RM. Lipoprotein subfractions and cardiovascular disease risk. Curr Opin Lipidol 2010; 21(4):305-311.
6. Griffin BA, Freeman DJ, Tait GW, Tomson J, Caslake MJ, Packard CJ, et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 1994; 106(2): 241-253.
7. Anber V, Griffin BA, McConnell M, Packard CJ, Shepherd J. Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans. Atherosclerosis 1996; 124 (2):261-271.
8. Regnstrom J, Nilsson J, Tornvall P, Landou C, Hamsten A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 1992; 339 (8803):1183-1186.
9. Tribble DL, Holl LG, Wood PD, Krauss RM. Variations in oxidative susceptibility among six low density lipoprotein subfractions of diff ering density and particle size. Atherosclerosis 1992; 93 (3):i89-199.
10. Deckelbaum RJ, Galeano NF. Small dense low density lipoprotein: formation and potential mechanisms for atherogenecity. Isr J Med Sci 1996; 32(6):464-468.
11. Stampfer JM, Krauss MR, Ma J, Blanche P, Holl GL, Sacks MF, et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter and risk of myocardial infarction. JAMA 1996; 276(ll):882-888.
12. Grundy SM. Small LDL, atherogenic dyslipidemia, and the metabolic syndrome. Circulation 1997; 95(1):1- 4.
13. Bruce C, Chouinard RA, Tall AR. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. Annu Rev Nutr 1998; 18:297-330.
14. Bruce C, Tall AR. Cholesteryl ester transfer proteins, reverse cholesterol transport, and atherosclerosis. Curr Opin Lipidol 1995; 6(5): 306-311.
15. Tall AR. An overview of reverse cholesterol transport. Eur Heart J 1998; 19Suppl A: A31-35.
16. Tall AR. Plasma cholesteryl ester transfer protein. J Lipid Res 1993; 34(8):1255-1274.
17. Tompson JF, Durham LK, Lira ME, Shear C, Milos PM. CETP polymorphisms associated with HDL cholesterol may differ from those associated with cardiovascular disease. Atherosclerosis 2005; 181(l):45-53.
18. Boekholdt SM, Sacks FM, Jukema JW, Shepherd J, Freeman DJ, McMahon AD. et al. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and effi cacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation 2005; 111(3): 278-287.
19. Barter PJ, Brewer HB Jr, Chapman MJ, Hennekens CH, Rader DJ, Tall AR. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler T romb Vasc Biol 2003;23(2): 160-167.
20. De Grooth GJ, Klerkx AH, Stroes ES, Stalenhoef AF, Kastelein JJ, Kuivenhoven JA. A review of CETP and its relation to atherosclerosis. J Lipid Res 2004; 45(11): 1967-1974.
21. Simon A, Megnien JL, Chironi G. The value of carotid intima-media thickness for predicting cardiovascular risk. Arterioscler T romb Vasc Biol 2010; 30(2):182-185.
22. Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002; 2o(2):i59-i69.
23. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Shar-rett AR. et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997;i46(6):483-494.
24. Chambless LE, Folsom AR, Clegg LX, Sharrett AR, Shahar E, Ni-eto FJ. et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2000;151 (5):478-487.
25. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007; 115 (4):459-467.
26. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18(6): 499-502.
27. Alabakovska SB, Todorova BB, Labudovic DD, Tosheska KN. Gradient gel electrophoretic separation of LDL and HDL subclasses on BioRad Mini Protean II and size phenotyping in healthy Macedonians. Clin Chim Acta 2002; 317(1-2):119-123.
28. Alabakovska SB, Todorova BB, Labudovic DD, Tosheska KN. LDL and HDL subclass distribution in patients with end-stage renal diseases. Clin Biochem 2002; 35(3): 211-216.
29. Alabakovska S, Labudovic D, Tosheska K, Spiroski M, Todorova B. Distribution of low density lipoprotein subclasses in Macedonian children. Med Sci Monit 2004; 10 (12): CR667-671.
30. Alabakovska SB, Labudovic DD, Tosheska KN, Spiroski MZ, Todorova BB. Low density lipoprotein subclass distribution in children with diabetes mellitus. Bratisl Lek Listy 2008; 109(4):155-159.
31. Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996; 276(11):875-881.
32. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lu-pien PJ, et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Circulation 1997; 95(1): 69-75.
33. Skoglund-Andersson C, Tang R, Bond MG, de Faire U, Hamsten A, Karpe F. LDL particle size distribution is associated with carotid intima media-thickness in healthy 50-year old men. Arterioscler T romb Vasc Biol 1999; 19(10): 2422-2430.
34. Klerkx AH, de Grooth GJ, Zwinderman AH, Jukema JW, Kuivenhoven JA, Kastelein JJ. Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS). Eur J Clin Invest 2004; 34(1): 21-28.
35. Okamura T, Sekikawa A, Kadowaki T, El-Saed A, Abbott RD, Curb JD, et al. Cholesteryl ester transfer protein, coronary calcium, and intima-media thickness of the carotid artery in middle-age Japanese men. Am J Cardiol 2009; 104(6):818-822.
36. Boekholdt SM, Kuivenhoven JA, Wareham NJ, Peters RJ, Jukema JW, Luben R, et al. Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition) -Norfolk population study. Circulation 2004; 110 (11):1418-1423.
37. Borggreve SE, Hillege HL, Dallinga-Tie GM, de Jong PE, Wolffen-buttel BH, Grobbee DE, et al. PREVEND Study Group. High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides. Eur Heart J 2007; 28 (8):1012-1018.
38. Dogan S, Duivenvoorden R, Grobbee DE, Kastelein JJ, Shear CL, Evans GW, et al. Radiance 1 and 2 Study Groups. Completeness of carotid intima media thickness measurements depends on body composition: the RADIANCE 1 and 2 trials. J Atheroscler T romb 2010; 17(5): 526-535.
39. De Grooth GJ, Smilde TJ, Van Wissen S, Klerkx AH, Zwinderman AH, Fruchart JC, et al. T e relationship between cholesteryl ester transfer protein levels and risk factor profi le in patients with familial hypercholesterolemia. Atherosclerosis 2004; 173(2): 261-267.
40. Zhuang Y, Wang J, Qiang H, Li Y, Lui X, Li L, et al. Serum cholesteryl ester transfer protein concentrations in healthy Chinese subjects and cardio-cerebrovascular disease patients. Clin Chim Acta 2001; 305 (1-2):19-25.
41. Foger B, Luef G, Ritsch A, Schmidauer C, Doblinger A, Lechleitner M, et al. Relationship of high-density lipoprotein subfractions and cholesteryl ester transfer protein in plasma to carotid artery wall thickness. J Mol Med 1995; 73(7): 369-372.